DOI QR코드

DOI QR Code

Acute Cytotoxicity Testing of Polyhexamethylene-biguanide (PHMG) and Epigallocatechin-gallate (EGCG) Mixture on the Cultured Human Corneal Epithelial Cell

보존제 PHMB(polyhexamethylene biguanide)-EGCG(epigallocatechin gallate) 혼합물의 각막상피세포 급성독성 평가

  • 김남열 (한국파스퇴르연구소) ;
  • 이군자 (을지대학교 보건과학대학 안경광학과)
  • Received : 2018.11.28
  • Accepted : 2018.12.21
  • Published : 2018.12.31

Abstract

Purpose : To evaluate the acute cytotoxic effect of polyhexamethylene biguanide (PHMB), epigallocatechin gallate (EGCG) and PHMB/EGCG mixture on the cultured human corneal epithelial cell (HCEpiC). Methods : HCEpiCs were cultured in the media of HCEpiC containing 0.00001~0.005% PHMB, 0.001~5% EGCG and 0.00005% PHMB/0.05% EGCG mixture respectively for 30, 60, 120 and 240 min. Cultured HCEpiCs were fixed and stained with Draq5 and cell viability and apoptosis were evaluated using confocal microscope and ImageXpress $Ultra^{TM}$. Results : Cultured HCEpiC did not show cytotoxic effect at below 0.00005% PHMB and below 0.05% EGCG concentration. In the media containing 0.00005% PHMB/0.05% EGCG, acute cytototoxic effect was not found, whereas damaged HCEpiCS were increased and survival cells were decreased in the media incubated for 240 min. Conclusion : The mixture of 0.00005% PHMB/0.05% EGCG showed non acute cytotoxic effect on the cultured HCEpiCs, however it is needed to investigate its chronic cytotoxic effect.

목적 : 항균제 polyhexamethylene Biguanide(PHMB), epigallocatechin gallate(EGCG) 및 PHMB/EGCG 혼합물의 각막상피세포(primary human corneal epithelial cells, HCEpiCs)에 대한 급성독성을 평가하고자 하였다. 방법 : 각막상피세포를 0.00001~0.005% PHMB, 0.001~5% EGCG 및 0.00005% PHMB/0.05% EGCG 혼합물이 각각 포함된 배양액에서 30분, 60분, 120분 및 240분 동안 배양하였다. 배양한 각막상피세포를 고정한 다음 Draq 5로 염색하고 공초점현미경과 ImageXpress $Ultra^{TM}$를 이용하여 세포형태를 관찰하여 세포생존율과 세포자살(apoptosis)을 비교하였다. 결과 : 배양된 각막상피세포는 0.00005% 이하의 PHMB 농도 및 0.05% 이하의 EGCG 농도에서는 세포 독성이 나타나지 않았다. 0.00005% PHMB/0.05% EGCG 혼합물이 포함된 배양액에서 급성 세포독성은 관찰되지 않았으나 240분 배양시킨 경우에는 손상된 각막상피세포 수가 증가하고 생존 세포의 수는 감소하였다. 결론 : 항균 시너지 효과를 갖는다고 보고된 0.00005% PHMB/0.05% EGCG 혼합물의 경우 각막상피세포에 대한 급성독성은 없었으나 만성효과에 대해서는 추가적인 연구가 필요할 것으로 생각된다.

Keywords

References

  1. ISO 14729. Ophthalmic optics-Contact lens care products-Microbiological requirements and test methods for products and regimens for hygienic management of contact lenses. Geneva, Int Organization Standardization, 2001. https://www.iso.org/obp/ui/#iso:std:iso:14729:ed-1:v1:en
  2. Epstein SP, Ahdoot M et al.: Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther. 25(2), 113-119, 2009. https://www.ncbi.nlm.nih.gov/pubmed/19284328 https://doi.org/10.1089/jop.2008.0098
  3. Ogunbiyi L, Smith FX et al.: Disinfecting and preserving systems and methods of use, US Patents, US4758595A, 1988. https://patents.google.com/patent/US4758595
  4. Kim JM, Lee SJ et al.: Effects of benzalkonium chloride on the growth and survival of human corneal epithelial cells. J Korean Opthalmol Soc. 7(2), 189-195, 2002. http://www.riss.kr/link?id=A104881838
  5. Ko EG, Na MS et al.: Cytotoxicity of clone 1-5C-4 cell lines and effect on rabbit cornea by soft contact lens multi-purpose solution (MPS). J Korean Opthalmol Soc. 12(3), 19-25, 2007. http://www.riss.kr/link?id=A104881214
  6. Chuang EY, Li DQ et al.: Effects of contact lens multipurpose solutions on human corneal epithelial survival and barrier function. Eye Contact Lens 34(5), 281-286, 2008. http://www.riss.kr/link?id=O49968773 https://doi.org/10.1097/ICL.0b013e3181842518
  7. Carnt N, Jalbert I et al.: Solution toxicity in soft contact lens daily wear is associated with corneal inflammation. Optom Vis Sci. 84(4), 309-315, 2007. https://www.ncbi.nlm.nih.gov/pubmed/17435514 https://doi.org/10.1097/OPX.0b013e318046551b
  8. Jones L, MacDougall N et al.: Asymptomatic corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide- preserved care regimen. Optom Vis Sci. 79(12), 753-761, 2002. https://www.ncbi.nlm.nih.gov/pubmed/12512683 https://doi.org/10.1097/00006324-200212000-00007
  9. Zigler L, Cedrone R et al.: Clinical evaluation of silicone hydrogel lens wear with a new multipurpose disinfection care product. Eye Contact Lens 33(5), 236-243, 2007. https://www.ncbi.nlm.nih.gov/pubmed/17873626 https://doi.org/10.1097/ICL.0b013e318030c959
  10. Lucas, AD, Gordon EA et al.: Analysis of polyhexamethylene biguanide in multipurpose contact lens solutions. Talanta 80(2), 1016-1019, 2009. http://www.riss.kr/link?id=O52559510 https://doi.org/10.1016/j.talanta.2009.07.031
  11. Miller MJ, Callahan DE et al.: Disinfection efficacy of contact lens care solutions against ocular pathogens. CLAO J. 27(1), 16-22, 2001. https://www.ncbi.nlm.nih.gov/pubmed/11215601
  12. Scheuer C, Zhao F et al.: Multipurpose solutions and rates of biocidal efficacy. Eye Contact Lens 35(2), 88-91, 2009. https://www.ncbi.nlm.nih.gov/pubmed/19265330 https://doi.org/10.1097/ICL.0b013e318199b058
  13. Pfster RR, Burstein N: The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: A scanning electron microscope study. Invest Ophthalmol. 15(4), 246-259, 1976. https://www.ncbi.nlm.nih.gov/pubmed/1262158
  14. Creppy EE, Diallo A et al.: Study of epigenetic properties of poly(hexamethylene biguanide) hydrochloride (PHMB). Int J Environ Res Public Health 11(8), 8069-8092, 2014. https://www.ncbi.nlm.nih.gov/pubmed/25111876 https://doi.org/10.3390/ijerph110808069
  15. Graham HN: Green tea composition, consumption, and polyphenol chemistry. Prev Med. 21(3), 334-350, 1992. https://www.ncbi.nlm.nih.gov/pubmed/1614995 https://doi.org/10.1016/0091-7435(92)90041-F
  16. Deana R, Turetta L et al.: Green tea epigallocatechin-3-gallate inhibits platelet signalling pathways triggered by both proteolytic and non-proteolytic agonists. Thromb Haemost. 89(5), 866-874, 2003. https://www.ncbi.nlm.nih.gov/pubmed/12719785 https://doi.org/10.1055/s-0037-1613474
  17. Chyu KY, Babbidge SM et al.: Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 109(20), 2448-2453, 2004. https://www.ncbi.nlm.nih.gov/pubmed/15136500 https://doi.org/10.1161/01.CIR.0000128034.70732.C2
  18. Katiyar SK, Challa A et al.: Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 20(11), 2117-2124, 1999. https://www.ncbi.nlm.nih.gov/pubmed/10545414 https://doi.org/10.1093/carcin/20.11.2117
  19. Skrzydlewska E, Ostrowska J et al.: Green tea as a potent antioxidant in alcohol intoxication. Addict Biol. 7(3), 307-314, 2002. https://www.ncbi.nlm.nih.gov/pubmed/12126490 https://doi.org/10.1080/13556210220139523
  20. Sakanaka S, Kim M et al.: Antibacterial substances in Japanese green tea extract against Streptococcus mutans, a cariogenic bacterium. Agric Biol Chem. 53(9), 2307-2311, 1989. https://www.tandfonline.com/doi/abs/10.1080/00021369.1989.10869665
  21. Sakanaka S, Aizawa M et al.: Inhibitory effects of green tea polyphenols on growth and cellular adherence of an oral bacterium, Porphyromonas gingivalis. Biosci Biotechnol Biochem. 60(5), 745-749, 1996. https://www.ncbi.nlm.nih.gov/pubmed/8704303 https://doi.org/10.1271/bbb.60.745
  22. Sharquie KE, al-Turfi IA et al.: The antibacterial activity of tea in vitro and in vivo (in patients with impetigo contagiosa). J Dermatol. 27(11), 706-710, 2000. https://www.ncbi.nlm.nih.gov/pubmed/11138536 https://doi.org/10.1111/j.1346-8138.2000.tb02263.x
  23. Lim SM, Lee KJ: Synergistic antimicrobial effect of epigallocatechin-gallate (EGCG) and polyhexamethylene-biguanide (PHMB) mixture. Korean J Vis Sci. 14(4), 413-424, 2012. http://www.riss.kr/link?id=A99577202
  24. Hu ZQ, Zhao WH et al.: Epigallocatechin gallate synergy with ampicillin/sulbactam against 28 clinical isolate of methicillin-resistant staphylococcus aureus. J Antimicrob Chemother. 48(3), 361-364, 2001. https://academic.oup.com/jac/article/48/3/361/736065 https://doi.org/10.1093/jac/48.3.361
  25. Lee JY, Kim YS, Shin DH: Antimicrobial synergistic effect of linolenic acid and monoglyceride against Bacillus cereus and Staphylococcus aureus. J Agric Food Chem. 50(7), 2193-2199, 2002. http://www.riss.kr/link?id=O31498921 https://doi.org/10.1021/jf011175a
  26. Kruszewski FH, Walker TL et al.: Evaluation of a human corneal epithelial cell line as an in vitro model for assessing ocular irritation. Fundam Appl Toxicol 36(2), 130-140, 1997. https://www.ncbi.nlm.nih.gov/pubmed/9143482 https://doi.org/10.1006/faat.1997.2289
  27. Santodomingo-Rubido J, Mori O et al.: Cytotoxicity and antimicrobial activity of six multipurpose soft contact lens disinfecting solutions. Ophthalmic Physiol Opt 26(5), 476-482, 2006. http://www.riss.kr/link?id=O45211477 https://doi.org/10.1111/j.1475-1313.2006.00393.x
  28. McCanna DJ, Harrington KL et al.: Use of a human corneal epithelial cell line for screening the safety of contact lens care solutions in vitro. Eye Contact Lens 34(1), 6-12, 2008. http://www.riss.kr/link?id=O48437360 https://doi.org/10.1097/ICL.0b013e31804fa141
  29. Gorbet MB, Tanti NC et al.: Corneal epithelial cell biocompatibility to silicone hydrogel and conventional hydrogel contact lens packaging solutions. Mol Vis. 16, 272-282, 2010. https://www.ncbi.nlm.nih.gov/pubmed/20169012
  30. Kim N, Lee KJ: Cytotoxicity of multipurpose contact lens solutions on the cultured corneal epithelial cells evaluated by image analysis. J Korean Oph Opt Soc. 20(1), 51-60, 2015. http://www.riss.kr/link?id=A104881788 https://doi.org/10.14479/jkoos.2015.20.1.51
  31. Wolkoff P, Nojgaard J et al.: Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency. Occup Environ Med. 62(1), 4-12, 2005. https://www.ncbi.nlm.nih.gov/pubmed/15613602 https://doi.org/10.1136/oem.2004.016030
  32. Nichols JJ, King-Smith PE: Thickness of the pre-and post-contact lens tear film measured in vivo by interferometry. Invest Ophthalmol Vis Sci. 44(1), 68-77, 2003. https://www.ncbi.nlm.nih.gov/pubmed/12506057 https://doi.org/10.1167/iovs.02-0377
  33. Yoon Y, Yoo GC et al.: The inhibitory effect of multi-purpose solution on HCE and L929 cells. Korean J Vis Sci. 1(1), 81-88, 1999. http://www.riss.kr/link?id=A40129433
  34. Dutot M, Warnet JM et al.: Cytotoxicity of contact lens multipurpose solutions: role of oxidative stress, mitochondrial activity and P2X7 cell death receptor activation. Eur J Pharm Sci. 33(2), 138-145, 2008. https://www.ncbi.nlm.nih.gov/pubmed/18065213 https://doi.org/10.1016/j.ejps.2007.10.006
  35. Pfister RR, Burstein N: The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study. Invest Ophthalmol. 15(4), 246-259, 1976. https://www.ncbi.nlm.nih.gov/pubmed/1262158
  36. Santodomingo-Rubido J, Mori O et al.: Cytotoxicity and antimicrobial activity of six multipurpose soft contact lens disinfecting solutions. Ophthalmic Physiol Opt. 26(5), 476-482, 2006. https://doi.org/10.1111/j.1475-1313.2006.00393.x
  37. McCanna DJ, Harrington KL et al.: Use of a human corneal epithelial cell line for screening the safety of contact lens care solutions in vitro. Eye Contact Lens 34(1), 6-12, 2008. http://www.riss.kr/link?id=O48437360 https://doi.org/10.1097/ICL.0b013e31804fa141
  38. Tanti NC, Jones L et al.: Impact of multipurpose solutions released from contact lenses on corneal cells. Optom Vis Sci. 88(4), 483-492, 2011. http://www.riss.kr/link?id=O55666883 https://doi.org/10.1097/OPX.0b013e3182045967
  39. Powell CH, Lally JM et al.: Lipophilic versus hydrodynamic modes of uptake and release by contact lenses of active entities used in multipurpose solutions. Cont Lens Anterior Eye 33(1), 9-18, 2010. http://www.riss.kr/link?id=O53003133 https://doi.org/10.1016/j.clae.2009.10.006
  40. Rosenthal RA, Dassanayake NL et al.: Biocide uptake in contact lenses and loss of fungicidal activity during storage of contact lenses. Eye Contact Lens 32(6), 262-266, 2006. http://www.riss.kr/link?id=O45910443 https://doi.org/10.1097/ICL.0b013e31802b413f